[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Research Letter
    Health Policy
    January 3, 2020

    Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder

    Author Affiliations
    • 1National Clinician Scholars Program, University of Pennsylvania, Philadelphia
    • 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania
    • 3Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
    • 4Penn Injury Science Center, University of Pennsylvania, Philadelphia
    • 5Office of Medical Assistance Programs, Department of Human Services, Commonwealth of Pennsylvania, Harrisburg
    • 6The Hospital and Healthsystem Association of Pennsylvania, Harrisburg
    • 7Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
    JAMA Netw Open. 2020;3(1):e1918511. doi:10.1001/jamanetworkopen.2019.18511

    Pennsylvania experienced an 80% increase in emergency department (ED) visits for opioid overdose from 2016 to 2017.1 The engagement of patients with opioid use disorder (OUD) in treatment after hospital discharge is a key strategy in preventing subsequent opioid overdose.2,3 The Pennsylvania Department of Human Services established an incentive program to improve the rate of OUD follow-up treatment among Medicaid recipients.4 In the Opioid Hospital Quality Improvement Program, hospitals earned payment for designing and attesting to 4 distinct clinical pathways: (1) ED initiation of buprenorphine treatment, (2) warm handoff to community resources, (3) referral and treatment for pregnant patients, and (4) inpatient initiation of medication treatment. Payment of the full incentive ($193 000) was contingent on participation and attestation of all 4 pathways, with smaller incentives for partial participation. We evaluated participation in this program among hospitals.